Tag

Recombinant Proteins

Latest content

Toni Ertl, Senior Scientist at The Native Antigen Company

Recombinant protein advancements revolutionize assay development

Toni Ertl shares how The Native Antigen Company’s new human health recombinant proteins are advancing assay development in diagnostics and vaccine research

9 Apr 2026

Editorial ArticleLife Sciences

Antibody expertise and bespoke reagents elevate life sciences research

26 Mar 2026

Editorial ArticleLife Sciences

Scientists master protein complexity

2 Jan 2024

Editorial ArticleDrug discovery > Target Discovery

Optimizing cell line development workflows for therapeutics

13 Sept 2022

Editorial Articles

Editorial Article

Recombinant protein advancements revolutionize assay development

9 Apr 2026

Editorial Article

Antibody expertise and bespoke reagents elevate life sciences research

26 Mar 2026

Editorial Article

Scientists master protein complexity

2 Jan 2024

Editorial Article

Optimizing cell line development workflows for therapeutics

13 Sept 2022

Latest Videos

Product News

Simplify recombinant protein harvest and clarification processes with a unified solution platform

2 Oct 2024

Resources

SDS-PAGE gel and densitometry analysis confirming recombinant IgM composition and purity

White Papers

Improving rheumatoid arthritis assay consistency with recombinant RF IgM

16 Jun 2026

Application Note

Achieving reliable, quantitative hormone detection in immunoassays

5 Mar 2026

Workflow showing isotope labeled protein expression in insect cells with experimental optimization

Application Note

Effective site-specific isotopic labeling and expression optimization using BioExpress 2000 Media

24 Nov 2025

Scientific Poster

Measuring protein thermal stability and phosphorylation changes to capture early cellular responses to small molecule drugs

14 Nov 2023

News

Industry News

Development of an affinity chromatography resin by Navigo Proteins & Eleva for the efficient purification of Human Complement-Factor H

17 Mar 2021

Industry News

Harbour BioMed and ProBioGen agree on a GlymaxX license to fast-track cell line development projects

3 Feb 2021

Industry News

Aalto Bio Reagents launches first recombinant SARS-CoV-2 (COVID-19) nucleocapsid protein for diagnostic testing

25 Feb 2020

Industry News

ProBioGen Will License GlymaxX® to Thermo Fisher Scientific for Use in Developing Allergy Diagnostics

17 May 2016